BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1695804)

  • 21. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
    Devaney K; Goodman ZD; Ishak KG
    Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
    Tavassoli FA
    Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
    Ryuko K; Iwanari O; Kitao M; Moriwaki S
    Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G; Zippel HH; Würz H
    Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial sarcoma. An immunohistochemical study of the epithelial component.
    Jørgensen LJ; Lyon H; Myhre-Jensen O; Nordentoft A; Sneppen O
    APMIS; 1994 Mar; 102(3):191-6. PubMed ID: 7514419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
    Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
    Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
    Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
    Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
    Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
    Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
    Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
    Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial cell markers and proliferating cells in odontogenic jaw cysts.
    Matthews JB; Mason GI; Browne RM
    J Pathol; 1988 Dec; 156(4):283-90. PubMed ID: 2465398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.